203 related articles for article (PubMed ID: 24597649)
21. Type I IFNs downregulate myeloid cell IFN-γ receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription.
Kearney SJ; Delgado C; Eshleman EM; Hill KK; O'Connor BP; Lenz LL
J Immunol; 2013 Sep; 191(6):3384-92. PubMed ID: 23935197
[TBL] [Abstract][Full Text] [Related]
22. Ablation of Type-1 IFN Signaling in Hematopoietic Cells Confers Protection Following Traumatic Brain Injury.
Karve IP; Zhang M; Habgood M; Frugier T; Brody KM; Sashindranath M; Ek CJ; Chappaz S; Kile BT; Wright D; Wang H; Johnston L; Daglas M; Ates RC; Medcalf RL; Taylor JM; Crack PJ
eNeuro; 2016; 3(1):. PubMed ID: 27022620
[TBL] [Abstract][Full Text] [Related]
23. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains.
Takaoka A; Mitani Y; Suemori H; Sato M; Yokochi T; Noguchi S; Tanaka N; Taniguchi T
Science; 2000 Jun; 288(5475):2357-60. PubMed ID: 10875919
[TBL] [Abstract][Full Text] [Related]
24. Type I interferon is selectively required by dendritic cells for immune rejection of tumors.
Diamond MS; Kinder M; Matsushita H; Mashayekhi M; Dunn GP; Archambault JM; Lee H; Arthur CD; White JM; Kalinke U; Murphy KM; Schreiber RD
J Exp Med; 2011 Sep; 208(10):1989-2003. PubMed ID: 21930769
[TBL] [Abstract][Full Text] [Related]
25. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells.
Ireland DD; Stohlman SA; Hinton DR; Atkinson R; Bergmann CC
J Virol; 2008 Jan; 82(1):300-10. PubMed ID: 17928334
[TBL] [Abstract][Full Text] [Related]
26. In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection.
Kochs G; Anzaghe M; Kronhart S; Wagner V; Gogesch P; Scheu S; Lienenklaus S; Waibler Z
J Virol; 2016 Oct; 90(20):9330-7. PubMed ID: 27512061
[TBL] [Abstract][Full Text] [Related]
27. IFNAR1 Deficiency Impairs Immunostimulatory Properties of Neutrophils in Tumor-Draining Lymph Nodes.
Hussain T; Domnich M; Bordbari S; Pylaeva E; Siakaeva E; Spyra I; Ozel I; Droege F; Squire A; Lienenklaus S; Sutter K; Hasenberg A; Gunzer M; Lang S; Jablonska J
Front Immunol; 2022; 13():878959. PubMed ID: 35833131
[TBL] [Abstract][Full Text] [Related]
28. Organ-specific and differential requirement of TYK2 and IFNAR1 for LPS-induced iNOS expression in vivo.
Painz R; Walter I; Kolbe T; Rigler D; Vogl C; Steinborn R; Rülicke T; Helmreich M; Karaghiosoff M; Müller M
Immunobiology; 2007; 212(9-10):863-75. PubMed ID: 18086385
[TBL] [Abstract][Full Text] [Related]
29. Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis.
Tanaka MH; Giro EM; Cavalcante LB; Pires JR; Apponi LH; Valentini SR; Spolidório DM; Capela MV; Rossa C; Scarel-Caminaga RM
Cytokine; 2012 Dec; 60(3):875-81. PubMed ID: 22995210
[TBL] [Abstract][Full Text] [Related]
30. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
[TBL] [Abstract][Full Text] [Related]
31. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection.
Mack EA; Kallal LE; Demers DA; Biron CA
mBio; 2011; 2(4):. PubMed ID: 21828218
[TBL] [Abstract][Full Text] [Related]
32. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
Lamken P; Lata S; Gavutis M; Piehler J
J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
[TBL] [Abstract][Full Text] [Related]
33. The Role of Structure in the Biology of Interferon Signaling.
Walter MR
Front Immunol; 2020; 11():606489. PubMed ID: 33281831
[TBL] [Abstract][Full Text] [Related]
34. Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses.
Hwang M; Bergmann CC
J Virol; 2018 May; 92(10):. PubMed ID: 29491163
[TBL] [Abstract][Full Text] [Related]
35. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
36. A conserved IFN-alpha receptor tyrosine motif directs the biological response to type I IFNs.
Zhao W; Lee C; Piganis R; Plumlee C; de Weerd N; Hertzog PJ; Schindler C
J Immunol; 2008 Apr; 180(8):5483-9. PubMed ID: 18390731
[TBL] [Abstract][Full Text] [Related]
37. PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes.
Boasso A; Hardy AW; Landay AL; Martinson JL; Anderson SA; Dolan MJ; Clerici M; Shearer GM
Clin Immunol; 2008 Oct; 129(1):132-44. PubMed ID: 18650129
[TBL] [Abstract][Full Text] [Related]
38. Type I interferon plays opposing roles in cytotoxicity and interferon-γ production by natural killer and CD8 T cells after influenza A virus infection in mice.
Arimori Y; Nakamura R; Yamada H; Shibata K; Maeda N; Kase T; Yoshikai Y
J Innate Immun; 2014; 6(4):456-66. PubMed ID: 24435166
[TBL] [Abstract][Full Text] [Related]
39. Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.
Stifter SA; Bhattacharyya N; Pillay R; Flórido M; Triccas JA; Britton WJ; Feng CG
PLoS Pathog; 2016 Jan; 12(1):e1005378. PubMed ID: 26731100
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1.
de Weerd NA; Vivian JP; Nguyen TK; Mangan NE; Gould JA; Braniff SJ; Zaker-Tabrizi L; Fung KY; Forster SC; Beddoe T; Reid HH; Rossjohn J; Hertzog PJ
Nat Immunol; 2013 Sep; 14(9):901-7. PubMed ID: 23872679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
